PERCEPTIVE ADVISORS LLC Insider Trading Transactions
Get free email notifications about insider trading for PERCEPTIVE ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PERCEPTIVE ADVISORS LLC. PERCEPTIVE ADVISORS LLC is 10% Owner in LA JOLLA PHARMACEUTICAL CO ($LJPC) and 10% Owner in VBI VACCINES INC. ($VBIV) and in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in SCYNEXIS INC ($SCYX) and in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in Athenex, Inc. ($ATNX) and 10% Owner in ALBIREO PHARMA, INC. ($ALBO) and Director in Lyra Therapeutics, Inc. ($LYRA) and 10% Owner in VBI Vaccines Inc/BC ($VBIV) and 10% Owner in Aldeyra Therapeutics, Inc. ($ALDX) and 10% Owner in ADMA BIOLOGICS, INC. ($ADMA) and 10% Owner in ZOGENIX, INC. ($ZGNX) and 10% Owner in ACELRX PHARMACEUTICALS INC ($ACRX) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and 10% Owner in LEAP THERAPEUTICS, INC. ($LPTX) and 10% Owner in Versartis, Inc. ($VSAR) and in Kadmon Holdings, Inc. ($KDMN) and 10% Owner in Menlo Therapeutics Inc. ($MNLO) and 10% Owner in Corium International, Inc. ($CORI) and 10% Owner in Quotient Ltd ($QTNT) and 10% Owner in Athira Pharma, Inc. ($ATHA) and Director in Athira Pharma, Inc. ($ATHA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Verrica Pharmaceuticals Inc. ($VRCA) and 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and Director in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in Dova Pharmaceuticals, Inc. ($DOVA) and 10% Owner in Motus GI Holdings, Inc. ($MOTS) and 10% Owner in Prometheus Biosciences, Inc. ($RXDX) and 10% Owner in Rain Therapeutics Inc. ($RAIN) and Director in Solid Biosciences Inc. ($SLDB) and Director in MeiraGTx Holdings plc ($MGTX) and Director in Landos Biopharma, Inc. ($LABP) and Director in ARYA Sciences Acquisition Corp II ($ARYB).
Latest Insider Trading Transactions of PERCEPTIVE ADVISORS LLC
Sentiment: All, ACRX, ADMA, AGRX, ALBO, ALDX, FOLD, ARAV, ATNX, ATHA, CATB, CERE, CORI, CRNX, DOVA, GBT, KDMN, LJPC, LABP, LPTX, LYRA, MGTX, MOTS, RXDX, QTNT, RAIN, SCYX, SLDB, VBIV, VBIV, VRCA, MNLO, ZGNX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 17.94 | 130,000 | 2,332,200 | 9,726,022 | 9.6 M to 9.7 M (+1.35 %) |
Jun 18 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 17.69 | 324,290 | 5,736,690 | 9,596,022 | 9.3 M to 9.6 M (+3.50 %) |
Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 0.62 | 1,000,000 | 618,000 | 24,951,556 | 24 M to 25 M (+4.18 %) |
Jun 17 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 17.05 | 75,710 | 1,290,856 | 9,271,732 | 9.2 M to 9.3 M (+0.82 %) |
Jun 17 2019 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 5.26 | 10,000 | 52,600 | 10,000 | |
May 23 2019 | ADMA | ADMA BIOLOGICS, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 4.64 | 250,000 | 1,160,000 | 250,000 | |
May 23 2019 | ADMA | ADMA BIOLOGICS, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 3.28 | 1,360,000 | 4,457,400 | 1,360,000 | |
May 23 2019 | ADMA | ADMA BIOLOGICS, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.00 | 4,000,000 | 16,000,000 | 11,521,102 | 7.5 M to 11.5 M (+53.18 %) |
May 08 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.90 | 77,010 | 993,429 | 9,196,022 | 9.1 M to 9.2 M (+0.84 %) |
May 08 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.08 | 22,990 | 277,719 | 9,119,012 | 9.1 M to 9.1 M (+0.25 %) |
Jan 17 2019 | MOTS | Motus GI Holdings, ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 2.70 | 400,000 | 1,080,000 | 3,210,541 | 2.8 M to 3.2 M (+14.23 %) |
Jan 17 2019 | MOTS | Motus GI Holdings, ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.00 | 10,000 | 50,000 | 2,810,541 | 2.8 M to 2.8 M (+0.36 %) |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 5.26 | 450,235 | 2,368,236 | 2,253,376 | 2.7 M to 2.3 M (-16.65 %) |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 5.25 | 800,000 | 4,200,000 | 2,703,611 | 3.5 M to 2.7 M (-22.83 %) |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 6.46 | 25,800 | 166,668 | 3,503,611 | 3.5 M to 3.5 M (-0.73 %) |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 5.26 | 4,200 | 22,092 | 3,529,411 | 3.5 M to 3.5 M (-0.12 %) |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 6.46 | 25,800 | 166,668 | 3,533,611 | 3.6 M to 3.5 M (-0.72 %) |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 5.26 | 4,200 | 22,092 | 3,559,411 | 3.6 M to 3.6 M (-0.12 %) |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 9.52 | 4,592 | 43,716 | 3,563,611 | 3.6 M to 3.6 M (-0.13 %) |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 9.05 | 34,401 | 311,329 | 3,568,203 | 3.6 M to 3.6 M (-0.95 %) |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 7.56 | 131,866 | 996,907 | 3,602,604 | 3.7 M to 3.6 M (-3.53 %) |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 6.67 | 147,497 | 983,805 | 3,734,470 | 3.9 M to 3.7 M (-3.80 %) |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 5.64 | 431,644 | 2,434,472 | 3,881,967 | 4.3 M to 3.9 M (-10.01 %) |
Dec 17 2018 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.40 | 14,285,714 | 20,000,000 | 23,631,439 | 9.3 M to 23.6 M (+152.86 %) |
Dec 10 2018 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.50 | 2,000,000 | 13,000,000 | 10,789,054 | 8.8 M to 10.8 M (+22.76 %) |
Oct 15 2018 | CORI | Corium Internation ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 12.52 | 2,350,000 | 29,422,000 | 2,724,686 | 5.1 M to 2.7 M (-46.31 %) |
Oct 15 2018 | CORI | Corium Internation ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 12.51 | 500,000 | 6,255,000 | 5,074,686 | 5.6 M to 5.1 M (-8.97 %) |
Oct 15 2018 | CORI | Corium Internation ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 12.50 | 500,000 | 6,250,000 | 5,574,686 | 6.1 M to 5.6 M (-8.23 %) |
Oct 15 2018 | CORI | Corium Internation ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 12.51 | 282,447 | 3,533,412 | 6,074,686 | 6.4 M to 6.1 M (-4.44 %) |
Oct 05 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.69 | 30,000 | 380,700 | 20,724,424 | 20.7 M to 20.7 M (+0.14 %) |
Oct 05 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.45 | 20,000 | 249,000 | 20,694,424 | 20.7 M to 20.7 M (+0.10 %) |
Sep 25 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.53 | 50,000 | 626,500 | 20,674,424 | 20.6 M to 20.7 M (+0.24 %) |
Sep 17 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 11.74 | 100,000 | 1,174,000 | 20,624,424 | 20.5 M to 20.6 M (+0.49 %) |
Sep 14 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.00 | 500,000 | 6,001,500 | 20,524,424 | 20 M to 20.5 M (+2.50 %) |
Aug 14 2018 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 52.00 | 100,000 | 5,200,000 | 4,070,357 | 4 M to 4.1 M (+2.52 %) |
Aug 01 2018 | VRCA | Verrica Pharmaceut ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 2,193,463 | 0 | 0 | |
Aug 01 2018 | VRCA | Verrica Pharmaceut ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,937,984 | 0 | 0 | |
Aug 01 2018 | VRCA | Verrica Pharmaceut ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 15.00 | 1,000,000 | 15,000,000 | 3,410,412 | 2.4 M to 3.4 M (+41.49 %) |
Aug 01 2018 | VRCA | Verrica Pharmaceut ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,279,733 | 0 | 2,410,412 | 1.1 M to 2.4 M (+113.18 %) |
Aug 01 2018 | VRCA | Verrica Pharmaceut ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,130,679 | 0 | 1,130,679 | 0 to 1.1 M |
Aug 01 2018 | VRCA | Verrica Pharmaceut ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 2,193,463 | 0 | 0 | |
Aug 01 2018 | VRCA | Verrica Pharmaceut ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,937,984 | 0 | 0 | |
Aug 01 2018 | VRCA | Verrica Pharmaceut ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 15.00 | 1,000,000 | 15,000,000 | 3,410,412 | 2.4 M to 3.4 M (+41.49 %) |
Aug 01 2018 | VRCA | Verrica Pharmaceut ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,279,733 | 0 | 2,410,412 | 1.1 M to 2.4 M (+113.18 %) |
Aug 01 2018 | VRCA | Verrica Pharmaceut ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,130,679 | 0 | 1,130,679 | 0 to 1.1 M |
Jul 27 2018 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 37.89 | 1,835 | 69,528 | 1,835 | |
Jul 26 2018 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | Sell | S | 0.30 | 298,628 | 89,439 | 3,231,372 | 3.5 M to 3.2 M (-8.46 %) | |
Jul 26 2018 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | Sell | S | 0.30 | 298,628 | 89,439 | 3,231,372 | 3.5 M to 3.2 M (-8.46 %) | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 6,186,205 | 0 | 0 | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 17.00 | 400,000 | 6,800,000 | 2,280,305 | 1.9 M to 2.3 M (+21.27 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 1,880,305 | 0 | 1,880,305 | 0 to 1.9 M |
Jul 20 2018 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 5.80 | 2,306,034 | 13,374,997 | 0 | |
Jul 20 2018 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | X | 5.80 | 2,306,034 | 13,374,997 | 8,789,054 | 6.5 M to 8.8 M (+35.57 %) |
Jun 13 2018 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 29.82 | 5,591 | 166,724 | 3,125,851 | 3.1 M to 3.1 M (+0.18 %) |
Jun 13 2018 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 29.18 | 14,109 | 411,701 | 3,120,260 | 3.1 M to 3.1 M (+0.45 %) |
Jun 12 2018 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 28.97 | 2,000 | 57,940 | 3,106,151 | 3.1 M to 3.1 M (+0.06 %) |
Jun 12 2018 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 28.62 | 23,000 | 658,260 | 3,104,151 | 3.1 M to 3.1 M (+0.75 %) |
Jun 12 2018 | MGTX | MeiraGTx Holdings ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 15.00 | 1,333,333 | 19,999,995 | 4,703,398 | 3.4 M to 4.7 M (+39.56 %) |
Jun 12 2018 | MGTX | MeiraGTx Holdings ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 15.22 | 50,000 | 761,000 | 3,370,065 | 3.3 M to 3.4 M (+1.51 %) |
Jun 11 2018 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 29.16 | 8,400 | 244,944 | 3,081,151 | 3.1 M to 3.1 M (+0.27 %) |
Jun 11 2018 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 28.40 | 19,223 | 545,933 | 3,072,751 | 3.1 M to 3.1 M (+0.63 %) |
Jun 11 2018 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 27.63 | 22,377 | 618,277 | 3,053,528 | 3 M to 3.1 M (+0.74 %) |
Jun 08 2018 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 28.99 | 51,763 | 1,500,609 | 3,031,151 | 3 M to 3 M (+1.74 %) |
Jun 08 2018 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 28.30 | 48,237 | 1,365,107 | 2,979,388 | 2.9 M to 3 M (+1.65 %) |
Jun 06 2018 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 25.07 | 10,000 | 250,700 | 2,831,151 | 2.8 M to 2.8 M (+0.35 %) |
May 24 2018 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.65 | 231,992 | 1,542,747 | 6,483,020 | 6.3 M to 6.5 M (+3.71 %) |
May 24 2018 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.24 | 218,008 | 1,360,370 | 6,251,028 | 6 M to 6.3 M (+3.61 %) |
Mar 26 2018 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 29.50 | 700,000 | 20,650,000 | 4,313,611 | 3.6 M to 4.3 M (+19.37 %) |
Mar 07 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 13.56 | 335,827 | 4,553,814 | 18,424,424 | 18.1 M to 18.4 M (+1.86 %) |
Mar 06 2018 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 13.90 | 100,000 | 1,389,500 | 18,088,597 | 18 M to 18.1 M (+0.56 %) |
Feb 21 2018 | MOTS | Motus GI Holdings, ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | J | 5.00 | 180,055 | 900,275 | 180,055 | |
Feb 20 2018 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 32.42 | 50,000 | 1,621,000 | 3,613,611 | 3.6 M to 3.6 M (+1.40 %) |
Feb 15 2018 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 32.69 | 100,000 | 3,269,000 | 3,563,611 | 3.5 M to 3.6 M (+2.89 %) |
Feb 15 2018 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 32.75 | 75,000 | 2,456,250 | 3,463,611 | 3.4 M to 3.5 M (+2.21 %) |
Jan 30 2018 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 27.33 | 20,000 | 546,520 | 3,927,222 | 3.9 M to 3.9 M (+0.51 %) |
Jan 30 2018 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 16.00 | 1,000,000 | 16,000,000 | 3,907,222 | 2.9 M to 3.9 M (+34.40 %) |
Jan 25 2018 | ALBO | ALBIREO PHARMA, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 33.00 | 275,000 | 9,075,000 | 1,595,000 | 1.3 M to 1.6 M (+20.83 %) |
Jan 18 2018 | CORI | Corium Internation ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.80 | 310,000 | 3,968,000 | 6,357,133 | 6 M to 6.4 M (+5.13 %) |
Jan 18 2018 | CORI | Corium Internation ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.24 | 149,650 | 1,831,716 | 6,047,133 | 5.9 M to 6 M (+2.54 %) |
Jan 18 2018 | CORI | Corium Internation ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 11.83 | 50,350 | 595,641 | 5,897,483 | 5.8 M to 5.9 M (+0.86 %) |
Dec 19 2017 | GBT | Global Blood Thera ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 38.00 | 175,000 | 6,650,000 | 4,889,066 | 4.7 M to 4.9 M (+3.71 %) |
Oct 30 2017 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 3.05 | 3,100,000 | 9,455,000 | 9,345,725 | 6.2 M to 9.3 M (+49.63 %) |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 37.50 | 300,000 | 11,250,000 | 3,970,357 | 3.7 M to 4 M (+8.17 %) |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 27.67 | 22,055 | 610,341 | 3,670,357 | 3.6 M to 3.7 M (+0.60 %) |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 40.14 | 8,920 | 358,081 | 3,648,302 | 3.6 M to 3.6 M (+0.25 %) |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 39.22 | 12,586 | 493,600 | 3,639,382 | 3.6 M to 3.6 M (+0.35 %) |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 38.56 | 8,112 | 312,791 | 3,626,796 | 3.6 M to 3.6 M (+0.22 %) |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 37.14 | 6,153 | 228,530 | 3,618,684 | 3.6 M to 3.6 M (+0.17 %) |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 36.26 | 3,800 | 137,805 | 3,612,531 | 3.6 M to 3.6 M (+0.11 %) |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 34.91 | 6,000 | 209,475 | 3,608,731 | 3.6 M to 3.6 M (+0.17 %) |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 33.86 | 8,260 | 279,665 | 3,602,731 | 3.6 M to 3.6 M (+0.23 %) |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 32.96 | 15,937 | 525,311 | 3,594,471 | 3.6 M to 3.6 M (+0.45 %) |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 31.90 | 102,199 | 3,260,240 | 3,578,534 | 3.5 M to 3.6 M (+2.94 %) |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 31.19 | 28,033 | 874,220 | 3,476,335 | 3.4 M to 3.5 M (+0.81 %) |
Sep 25 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 3.35 | 350,000 | 1,172,500 | 2,099,563 | 2.4 M to 2.1 M (-14.29 %) |
Sep 25 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 3.27 | 500,000 | 1,633,250 | 2,449,563 | 2.9 M to 2.4 M (-16.95 %) |
Sep 25 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 3.17 | 250,000 | 792,500 | 2,949,563 | 3.2 M to 2.9 M (-7.81 %) |
Sep 25 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 3.03 | 250,000 | 757,250 | 3,199,563 | 3.4 M to 3.2 M (-7.25 %) |
Sep 25 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 3.09 | 300,000 | 926,250 | 3,449,563 | 3.7 M to 3.4 M (-8.00 %) |
Sep 25 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 3.56 | 353,421 | 1,258,143 | 3,749,563 | 4.1 M to 3.7 M (-8.61 %) |
Sep 25 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 3.74 | 126,579 | 473,659 | 4,102,984 | 4.2 M to 4.1 M (-2.99 %) |
Sep 21 2017 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.25 | 200,000 | 1,450,000 | 3,085,458 | 2.9 M to 3.1 M (+6.93 %) |
Jul 14 2017 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.25 | 1,500,000 | 18,375,000 | 17,888,597 | 16.4 M to 17.9 M (+9.15 %) |
Jun 21 2017 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 2.40 | 875,000 | 2,100,000 | 4,533,728 | 5.4 M to 4.5 M (-16.18 %) |
May 25 2017 | CORI | Corium Internation ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.25 | 1,902,400 | 11,890,000 | 5,546,129 | 3.6 M to 5.5 M (+52.21 %) |
Feb 15 2017 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.50 | 893,025 | 4,018,613 | 2,589,451 | 1.7 M to 2.6 M (+52.64 %) |
Feb 14 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 15.51 | 59,133 | 917,425 | 4,228,563 | 4.2 M to 4.2 M (+1.42 %) |
Feb 14 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.94 | 34,883 | 521,281 | 4,169,430 | 4.1 M to 4.2 M (+0.84 %) |
Feb 10 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.27 | 41,211 | 587,928 | 4,134,547 | 4.1 M to 4.1 M (+1.01 %) |
Feb 10 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 13.51 | 104,612 | 1,413,319 | 4,093,336 | 4 M to 4.1 M (+2.62 %) |
Jan 04 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.66 | 94,750 | 1,388,846 | 4,013,411 | 3.9 M to 4 M (+2.42 %) |
Jan 04 2017 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.96 | 94,750 | 470,055 | 16,293,847 | 16.2 M to 16.3 M (+0.58 %) |
Dec 30 2016 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.37 | 47,375 | 680,589 | 3,918,661 | 3.9 M to 3.9 M (+1.22 %) |
Dec 30 2016 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.85 | 94,750 | 459,917 | 16,293,847 | 16.2 M to 16.3 M (+0.58 %) |
Dec 30 2016 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.91 | 47,375 | 232,706 | 16,199,097 | 16.2 M to 16.2 M (+0.29 %) |
Dec 27 2016 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.92 | 37,900 | 186,582 | 16,151,722 | 16.1 M to 16.2 M (+0.24 %) |
Dec 27 2016 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.72 | 47,375 | 223,468 | 16,113,822 | 16.1 M to 16.1 M (+0.29 %) |
Dec 23 2016 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.51 | 189,500 | 854,835 | 16,066,447 | 15.9 M to 16.1 M (+1.19 %) |
Dec 08 2016 | VBIV | VBI VACCINES INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 3.36 | 1,341,282 | 4,500,001 | 2,068,824 | |
Dec 08 2016 | VBIV | VBI VACCINES INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 4.13 | 363,771 | 1,502,374 | 727,542 | |
Dec 08 2016 | VBIV | VBI VACCINES INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 3.05 | 3,383,955 | 10,321,063 | 6,213,314 | 2.8 M to 6.2 M (+119.60 %) |
Sep 30 2016 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 3.88 | 97,200 | 377,117 | 5,386,410 | 5.5 M to 5.4 M (-1.77 %) |
Sep 30 2016 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 3.96 | 119,300 | 472,380 | 5,483,610 | 5.6 M to 5.5 M (-2.13 %) |
Sep 16 2016 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 3.63 | 115,923 | 420,511 | 5,602,910 | 5.7 M to 5.6 M (-2.03 %) |
Sep 16 2016 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 3.73 | 276,927 | 1,032,301 | 5,718,833 | 6 M to 5.7 M (-4.62 %) |
Aug 26 2016 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | Sell | S | 6.81 | 1,100,000 | 7,491,000 | 14,139,444 | 15.2 M to 14.1 M (-7.22 %) | |
May 26 2016 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.00 | 700,000 | 3,500,000 | 1,940,458 | 1.2 M to 1.9 M (+56.43 %) |
Nov 19 2015 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 5.35 | 42,300 | 226,132 | 5,995,760 | 6 M to 6 M (-0.70 %) |
Nov 19 2015 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 5.36 | 133,900 | 717,409 | 6,038,060 | 6.2 M to 6 M (-2.17 %) |
Nov 09 2015 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 4.47 | 17,100 | 76,365 | 6,171,960 | 6.2 M to 6.2 M (-0.28 %) |
Nov 09 2015 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 4.62 | 75,000 | 346,260 | 6,189,060 | 6.3 M to 6.2 M (-1.20 %) |
Nov 05 2015 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.50 | 45,100 | 293,150 | 1,240,458 | 1.2 M to 1.2 M (+3.77 %) |
Oct 28 2015 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.46 | 50,000 | 323,150 | 1,195,358 | 1.1 M to 1.2 M (+4.37 %) |
Oct 26 2015 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.47 | 18,020 | 116,661 | 1,145,358 | 1.1 M to 1.1 M (+1.60 %) |
Oct 22 2015 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.44 | 22,797 | 146,858 | 1,127,338 | 1.1 M to 1.1 M (+2.06 %) |
Oct 22 2015 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.30 | 14,348 | 90,335 | 1,104,541 | 1.1 M to 1.1 M (+1.32 %) |
Oct 08 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.27 | 50,000 | 313,500 | 15,239,444 | 15.2 M to 15.2 M (+0.33 %) |
Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.34 | 7,000 | 44,380 | 15,189,444 | 15.2 M to 15.2 M (+0.05 %) |
Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.47 | 14,000 | 90,580 | 15,182,444 | 15.2 M to 15.2 M (+0.09 %) |
Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.65 | 14,000 | 93,100 | 15,168,444 | 15.2 M to 15.2 M (+0.09 %) |
Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.34 | 43,000 | 272,620 | 15,154,444 | 15.1 M to 15.2 M (+0.28 %) |
Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.47 | 86,000 | 556,420 | 15,111 | -70,889 to 15.1 K (-121.32 %) |
Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.65 | 86,000 | 571,900 | 15,025,444 | 14.9 M to 15 M (+0.58 %) |
Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.76 | 35,000 | 236,600 | 14,939,444 | 14.9 M to 14.9 M (+0.23 %) |
Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.85 | 35,000 | 239,750 | 14,904,444 | 14.9 M to 14.9 M (+0.24 %) |
Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.76 | 215,000 | 1,453,400 | 14,869,444 | 14.7 M to 14.9 M (+1.47 %) |
Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.85 | 215,000 | 1,472,750 | 14,654,444 | 14.4 M to 14.7 M (+1.49 %) |
Sep 11 2015 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 4.18 | 310,000 | 1,294,777 | 6,264,060 | 6.6 M to 6.3 M (-4.72 %) |
Aug 18 2015 | VBIV | VBI VACCINES INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 2.08 | 650,000 | 1,352,000 | 3,260,356 | 2.6 M to 3.3 M (+24.90 %) |